Voya Investment Management LLC Precision Biosciences Inc Transaction History

Voya Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.15 - $3.34 $25,239 - $73,302	-21,947 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.96 - $7.76 $8,533 - $22,372	2,883 Added 15.12%	21,947 $68,000
Q4 2021 Feb 14, 2022	BUY	$7.4 - $11.66 $1,354 - $2,133	183 Added 0.97%	19,064 $141,000
Q2 2021 Aug 16, 2021	SELL	$8.07 - $12.52 $19,989 - $31,012	-2,477 Reduced 11.6%	18,881 $236,000
Q1 2021 May 17, 2021	BUY	$8.57 - $15.79 $10,052 - $18,521	1,173 Added 5.81%	21,358 $221,000
Q4 2020 Feb 16, 2021	BUY	$5.98 - $12.47 $23,298 - $48,583	3,896 Added 23.92%	20,185 $168,000
Q2 2020 Aug 14, 2020	SELL	$4.66 - $8.7 $5,815 - $10,857	-1,248 Reduced 7.12%	16,289 $136,000
Q4 2019 Feb 14, 2020	BUY	$6.32 - $19.66 $110,833 - $344,777	17,537 New	17,537 $244,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $554M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.